½Å°æÁúȯ ½ÃÀåÁ¶»çº¸°í¼­

½Å°æÁúȯ(Neurodegenerative Disease) Ä«Å×°í¸®¿¡¼­´Â ½Å°æº¯¼º Áúȯ(´Ù¹ß¼º°æÈ­Áõ(MS), Ä¡¸Å, ¾ËÃ÷ÇÏÀ̸Ӻ´, °£Áú µî)À» Á¶»ç ´ë»óÀ¸·Î ÇÑ º¸°í¼­¸¦ ¼Ò°³ÇØ µå¸®°í ÀÖ½À´Ï´Ù. ÁßÃ߽Űæ°è ¾à¹° ÆÄÀÌÇÁ¶óÀÎ ¹× ¿¬±¸°³¹ß °ü·Ã °úÁ¦, ½ÃÀåÀÇ °¡´É¼º µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÑ º¸°í¼­µµ Çѵ¥ ¸ð¾Ò½À´Ï´Ù.

1 - 25 (Àüü: 590°Ç)
¼¼°èÀÇ ½ÉÀüµµ ºÎÇÏ °Ë»ç ½ÃÀå
ECG Stress Test
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¿ø°Ý °£Áú ½ÃÀå
Tele-Epilepsy
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½Å°æÅë Ä¡·á ½ÃÀå
Neuralgia Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ä¡¸Å Ä¡·á ½ÃÀå
Dementia Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³úÁøÅÁ ½ÃÀå
Concussion
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °£Áú Ä¡·á ½ÃÀå : ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Epilepsy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,995 £Ü 7,050,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ µ¿¹°¿ë ½Å°æ ÅðÇ༺ Áúȯ Áø´Ü ½ÃÀå : Á¦Ç° À¯Çüº°, Áø´Ü Å×½ºÆ®º°, µ¿¹° À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - ±âȸ ¹× ¿¹Ãø(2018-2032³â)
Global Veterinary Neurodegenerative Disease Diagnostics Market Assessment, By Product Type, By Diagnostic Tests, By Animal Type, By Indication, By End-Use, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,800 £Ü 6,775,000 (ºÎ°¡¼¼ º°µµ)
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³­Ä¡¼º °£Áú Ä¡·á ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2025-2035³â)
Asia-Pacific Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 3,250 £Ü 4,587,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º ½Å°æÀå¾Ö °ü¸® ½ÃÀå
Diabetic Neuropathy Management
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ º¹ÇÕºÎÀ§ ÅëÁõ ÁõÈıº ½ÃÀå
Complex Regional Pain Syndrome
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³ú°æ»ö Ä¡·á ½ÃÀå
Cerebral Infarction Treatment
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀüµÎÃøµÎ¿± Ä¡¸Å ½ÃÀå - »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ¾àÁ¦ Ŭ·¡½ºº°, ÀûÀÀ Áúȯº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Frontotemporal Dementia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Disease Indication, By Distribution Channel, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,500 £Ü 6,351,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾ËÃ÷ÇÏÀ̸Ӻ´ Áø´Ü ½ÃÀå
Alzheimer's Disease Diagnostics
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ ÇåÆÃÅϺ´ Ä¡·á ½ÃÀå Æò°¡ : ÀǾàǰ À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2018-2032³â)
United States Huntington's Disease Treatment Market Assessment, By Drug Type [Approved Drugs, Off-Label Drugs], By Distribution Channel [Hospital Pharmacies, Online Pharmacies, Retail Pharmacies], By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 3,500 £Ü 4,940,000 (ºÎ°¡¼¼ º°µµ)
À¯·´ÀÇ ³­Ä¡¼º °£Áú Ä¡·á ½ÃÀå : ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Europe Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 3,250 £Ü 4,587,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °¡¹ÙÆæÆ¾(Gabapentin) ½ÃÀå
Gabapentin
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³ú¿° Ä¡·á ½ÃÀå
Encephalitis Treatment
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,257,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇׯÄŲ½¼º´Á¦ ½ÃÀå(-2030³â)
Anti-Parkinson's Drugs: Global Markets to 2030
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,650 £Ü 6,563,000 (ºÎ°¡¼¼ º°µµ)
½Å°æº´Áõ¼º ÅëÁõ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Neuropathic Pain Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,995 £Ü 7,050,000 (ºÎ°¡¼¼ º°µµ)
°æÁ÷ Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, À¯Çüº°, ¾àÁ¦ Ŭ·¡½ºº°, ÃÖÁ¾»ç¿ëÀÚº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Spasticity Treatment Market Size, Share, and Growth Analysis, By Type, By Drug Class, By End-user, By Indication, By Route Of Administration, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,480,000 (ºÎ°¡¼¼ º°µµ)
½Å°æ ÅðÇ༺ Áúȯ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, ¾àÁ¦ Ŭ·¡½ºº°, ÀûÀÀ Áúȯº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Neurodegenerative Disease Market Size, Share, and Growth Analysis, By Drug Class, By Disease Indication, By Route of Administration, By End User, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,480,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È­Çпä¹ý À¯¹ß¼º ¸»ÃʽŰ溴Áõ Ä¡·á ½ÃÀå ±âȸ ¹× Àü·«(-2034³â)
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Opportunities And Strategies To 2034
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,337,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¸¸¼º ¿°Áõ¼º Å»¼öÃʼº ´Ù¹ß½Å°æ¿° ½ÃÀå : À¯Åë ä³Î, Åõ¿© °æ·Î, Áö¿ªº° ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Chronic Inflammatory Demyelinating Polyneuropathy Market - A Global and Regional Analysis: Focus on Distribution Channel, Route of Administration, and Region - Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,900 £Ü 6,916,000 (ºÎ°¡¼¼ º°µµ)
ÇÁ·¹°¡¹ß¸° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : Á¦Çüº°, ¿ëµµº°, ¾à¹° Á¾·ùº°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Pregabalin Market Size, Share, and Growth Analysis, By Forms (Oral Capsule, Oral Solution), By Application (Epilepsy, Neuropathic Pain), By Drug Class, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,480,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÃµÀå°üÀý¿° Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Sacroiliitis Treatment Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,337,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.